medic
journal
australia
issn
june
medic
journal
australia
wwwmjacomau
bench
bedsid
n
year
sinc
structur
dna
elucid
human
genom
complet
sequenc
gene
identifi
howev
understand
function
gene
attent
turn
protein
encod
proteom
protein
respons
function
divers
cell
perform
biolog
function
level
mani
regulatori
process
take
place
mani
diseas
process
occur
drug
target
found
genom
studi
gene
proven
inadequ
predict
structur
dynam
properti
protein
new
field
proteom
develop
box
largescal
studi
protein
express
structur
function
aim
correl
structur
function
divers
protein
underli
biolog
process
includ
diseas
process
proteom
creat
opportun
identifi
investig
target
protein
differenti
express
health
diseas
clinic
research
pois
benefit
enorm
studi
potenti
develop
better
diagnost
prognost
test
identifi
new
therapeut
target
ultim
allow
patientindividualis
therapi
describ
proteom
technolog
use
studi
diseas
potenti
improv
diagnosi
treatment
rang
condit
proteom
made
possibl
number
develop
technolog
informat
box
commonli
use
highli
versatil
techniqu
separ
protein
accord
size
charg
protein
bodi
fluid
tissu
cell
first
separ
thin
gel
layer
accord
isoelectr
charg
first
dimens
gel
place
across
larger
gel
protein
separ
second
dimens
right
angl
first
accord
size
techniqu
separ
resolv
protein
per
gel
individu
protein
excis
purifi
identif
usual
mass
spectrometri
see
box
mass
spectrometri
revolutionis
proteom
allow
thousand
protein
analys
rapidli
first
develop
earli
centuri
techniqu
identifi
substanc
sort
accord
mass
stream
electrifi
particl
ion
deriv
substanc
applic
mass
spectrometri
protein
made
possibl
develop
method
ionis
larg
biomolecul
without
destroy
includ
electrospray
ionis
matrixassist
laser
desorpt
ionis
maldi
mass
spectrometri
protein
digest
enzym
usual
trypsin
cleav
specif
amino
acid
sequenc
result
peptid
fragment
energis
often
laser
eg
use
maldi
sometim
electrospray
ionis
charg
peptid
fragment
separ
spectromet
accord
masstocharg
ratio
method
vari
differ
type
spectromet
eg
time
flight
tof
flight
tube
separ
fragment
imping
detector
measur
signal
intens
fragment
graph
signal
intens
masstocharg
ratio
mass
spectrum
box
contain
seri
peak
correspond
particular
peptid
fragment
specif
amino
acid
sequenc
indic
mass
height
repres
rel
abund
fragment
peptid
peak
fragment
give
second
tandem
mass
spectrum
peptid
fragment
differ
neighbour
one
amino
acid
peptid
sequenc
determin
process
term
peptid
mass
fingerprint
peptid
sequenc
interrog
protein
databas
identifi
origin
protein
identif
protein
peptid
sequenc
deriv
mass
spectrum
facilit
develop
proteom
diseas
opportun
challeng
sinc
human
genom
sequenc
intens
activ
understand
function
identifi
gene
attent
turn
product
gene
protein
proteom
largescal
studi
structur
function
protein
includ
rapidli
evolv
field
diseas
proteom
aim
identifi
protein
involv
human
diseas
understand
express
structur
function
caus
ill
proteom
identifi
protein
offer
promis
diagnost
prognost
marker
therapeut
target
rang
ill
includ
cancer
immun
reject
transplant
infecti
diseas
tuberculosi
malaria
potenti
allow
patienttailor
therapi
major
challeng
remain
technic
eg
detect
lowabund
protein
maintain
sampl
stabil
data
manag
eg
correl
chang
protein
entrez
search
retriev
system
tool
access
search
larg
rang
databas
includ
protein
databas
literatur
databas
pubm
made
avail
us
nation
center
biotechnolog
inform
ncbi
nation
librari
medicin
protein
entri
system
contain
amino
acid
sequenc
protein
databas
swissprot
pir
prf
pdb
well
amino
acid
sequenc
translat
dna
sequenc
genet
databas
genbank
continu
develop
improv
proteom
technolog
differencegel
dige
box
liquid
chromatographi
link
mass
spectrometri
allow
protein
detect
high
sensit
specif
small
volum
biolog
sampl
blood
urin
plasma
protein
current
detect
concentr
rang
develop
mass
spectromet
combin
techniqu
remov
interf
protein
immunodeplet
enabl
even
lower
concentr
detect
addit
protein
microarray
system
chip
develop
matrixsupport
surfac
bind
select
protein
prepar
mass
spectrometri
analog
dna
chip
protein
chip
aim
bind
individu
protein
biolog
sampl
serum
urin
allow
highthroughput
screen
diseaseassoci
protein
identif
examin
diseas
marker
current
base
individu
protein
alway
reliabl
exampl
assay
prostat
serum
antigen
psa
use
screen
prostat
cancer
level
antigen
also
rais
benign
condit
prostat
advanc
proteom
technolog
allow
simultan
analysi
thousand
low
molecular
weight
protein
may
reveal
pattern
diseas
potenti
use
earli
detect
assess
prognosi
potenti
therefor
exist
use
panel
diagnost
marker
accur
identifi
given
diseas
state
proteom
diseas
studi
focus
cancer
proteom
potenti
allow
earlier
diagnosi
particularli
import
ovarian
cancer
women
cancer
advanc
diseas
diagnosi
surviv
rate
howev
stage
ovarian
cancer
genom
studi
gene
organ
genom
includ
systemat
use
gene
inform
associ
regul
gene
provid
answer
biolog
medicin
branch
genom
includ
genet
analysi
measur
gene
express
determin
gene
function
proteom
entir
protein
complement
given
cell
tissu
organ
proteom
largescal
studi
protein
express
structur
function
term
analog
genom
although
proteom
much
complex
genom
branch
proteom
includ
protein
separ
identif
quantif
protein
sequenc
analysi
structur
proteom
interact
proteom
protein
modif
broader
sens
proteom
involv
protein
activ
modif
interact
locat
organ
cell
first
mass
spectrographi
techniqu
describ
english
scientist
thompson
twodimension
polyacrylamid
gel
electrophoresi
describ
separ
protein
escherichia
coli
swissprot
establish
first
major
protein
knowledgebas
maintain
collabor
european
institut
sinc
includ
depart
medic
biochemistri
univers
geneva
tanaka
colleagu
describ
matrixassist
laser
desorpt
ionis
maldi
allow
larg
biomolecul
analys
rapidli
effici
entrez
establish
search
retriev
system
major
databas
includ
protein
genet
databas
us
nation
institut
health
fenn
colleagu
describ
applic
electrospray
ionis
biomolecul
peptid
mass
fingerprint
applic
mass
spectrometri
protein
develop
fast
effici
method
identifi
frequent
observ
protein
electrophoresi
gel
seldom
use
need
specialis
instrument
develop
commerci
instrument
base
maldi
mass
spectrometri
allow
widespread
use
peptid
mass
fingerprint
quantit
analysi
complex
protein
mixtur
use
isotopecod
affin
tag
describ
highli
sensit
protein
detect
techniqu
develop
includ
differencegel
dige
fluorescencebas
proteinlabel
separ
method
high
throughput
screen
serum
protein
pattern
diagnost
use
surfac
enhanc
laser
desorptionionis
time
flight
selditof
mass
spectrometri
protein
array
immunodeplet
techniqu
refin
came
routin
use
allow
remov
highabund
protein
give
access
lowabund
protein
interest
still
come
develop
databas
protein
differ
tissu
cell
bodi
fluid
health
diseas
differ
diseas
stage
databas
link
multipl
paramet
express
specif
protein
cellular
pathway
eg
apoptosi
differenti
prolifer
migrat
invas
genet
data
diseas
state
assist
accur
rapid
diagnosi
surviv
rate
earli
diagnosi
like
directli
affect
mortal
proteom
studi
identifi
serum
protein
pattern
distinguish
patient
ovarian
cancer
unaffect
women
posit
predict
valu
howev
number
assess
small
result
proven
difficult
reproduc
highlight
need
identifi
protein
interest
determin
biolog
plausibl
test
also
undertak
prospect
populationbas
assess
determin
valu
proteom
pattern
screen
tool
ovarian
cancer
identifi
protein
involv
also
import
potenti
therapeut
target
case
cancer
abdomen
occasion
difficult
determin
tissu
origin
consequ
optim
therapi
exampl
ovarian
colon
cancer
difficult
distinguish
correct
diagnosi
essenti
treatment
vari
markedli
use
combin
genom
proteom
tool
investig
abl
identifi
differenti
marker
two
cancer
protein
villin
colon
cancer
cell
moesin
ovarian
cancer
cell
tuberculosi
affect
million
peopl
worldwid
drugresist
mycobacterium
tuberculosi
strain
increas
problem
serum
screen
test
could
detect
preclin
infect
would
allow
earli
treatment
potenti
reduc
transmiss
widespread
applic
proteom
techniqu
identifi
protein
secret
vitro
common
clinic
isol
two
shown
potenti
serodiagnost
antigen
sensit
specif
clinic
studi
protein
potenti
candid
kitbas
serum
screen
test
pathogenesi
sever
acut
respiratori
syndrom
sar
well
understood
specif
diagnost
method
critic
manag
control
diseas
proteom
analysi
sera
patient
sar
identifi
potenti
protein
marker
truncat
form
antitrypsin
consist
found
higher
concentr
sera
sar
patient
compar
healthi
control
marker
may
prove
use
diagnost
tool
therapeut
target
moreov
studi
protein
structur
sar
viru
may
reveal
potenti
vaccin
target
applic
prognosi
immun
reject
major
problem
cardiac
transplant
accur
diagnosi
reli
invas
endomyocardi
biopsi
recent
studi
cardiac
biopsi
specimen
identifi
protein
upregul
reject
includ
cardiac
heat
shock
protein
latter
upregul
stress
respons
two
heat
shock
protein
tropomyosin
cardiac
muscl
protein
express
significantli
higher
level
sera
patient
undergo
reject
proteom
analysi
serum
may
therefor
power
less
invas
method
identifi
cardiac
reject
although
still
infanc
proteom
strategi
also
use
investig
differenti
protein
express
cancer
cell
may
reflect
differ
invas
predisposit
develop
resist
treatment
exampl
proteom
identifi
protein
involv
multidrug
resist
major
vault
protein
metastasi
cystatin
b
highli
express
glioblastoma
multiform
compar
normal
brain
tissu
protein
potenti
diagnost
drug
resist
invas
marker
glioblastoma
tumor
identifi
proteom
profil
associ
intrins
acquir
drug
resist
might
allow
treatment
vari
avoid
resist
hypothet
might
also
possibl
identifi
tumour
highli
drugrespons
allow
lower
drug
dose
use
potenti
reduc
drug
toxic
resist
cancer
cell
chemotherapi
multifacet
understand
caus
could
improv
use
exist
therapi
potenti
reveal
new
treatment
strategi
recent
proteom
studi
childhood
acut
lymphoblast
leukaemia
cell
identifi
specif
protein
chang
drugresist
compar
drugsensit
cell
identifi
protein
differ
structur
quantiti
cell
resist
vinca
alkaloid
sensit
cytoskelet
protein
eg
actin
protein
regul
bind
cytoskelet
protein
eg
heat
shock
protein
protein
involv
rna
process
eg
heterogen
nuclear
ribonuclear
proteinf
protein
previous
associ
drug
resist
studi
way
determin
potenti
novel
drug
target
treat
resist
diseas
addit
novel
antimitot
agent
epothilon
current
undergo
clinic
trial
cancer
treatment
studi
combin
biochem
proteom
approach
identifi
uniqu
chang
mutat
affect
tubulin
cellular
target
epothilon
drugresist
leukaemia
cell
found
epothiloneresist
leukaemia
cell
crossresist
paclitaxel
hypersensit
vinca
alkaloid
studi
demon
c
protein
sampl
digest
proteas
trypsin
inject
mass
spectromet
individu
peptid
fragment
energis
eg
laser
made
fli
toward
detector
speed
depend
size
charg
spectromet
provid
readout
abund
individu
peptid
fragment
versu
masstocharg
ratio
databas
search
identifi
protein
e
diagnost
prognost
therapeut
target
identifi
size
charg
abund
mass
spectrum
masstocharg
ratio
strate
laboratori
studi
target
specif
protein
alter
reveal
altern
treatment
approach
drug
resist
also
major
clinic
problem
treatment
mani
infecti
diseas
mani
case
mechan
unknown
genet
proteinsequ
data
avail
mani
microorgan
provid
tool
understand
resist
drug
identifi
novel
agent
treat
drugresist
diseas
exampl
azol
resist
candida
albican
link
differenti
express
protein
protein
involv
ergosterol
biosynthesi
pathway
potenti
drug
target
treatment
resist
diseas
chloroquin
one
success
drug
treat
malaria
render
virtual
ineffect
mani
part
world
widespread
emerg
chloroquin
resist
proteom
technolog
play
major
role
identifi
potenti
therapeut
target
plasmodium
speci
well
hostpathogen
interact
proteindrug
interact
advanc
date
includ
identif
differ
plasmodium
speci
identif
immun
target
vaccin
immun
protect
better
understand
cellular
target
chloroquin
mechan
chloroquin
resist
proteom
expect
major
impact
drug
develop
near
futur
protein
differenti
express
health
diseas
potenti
drug
target
test
commerci
avail
librari
chemic
compound
identifi
lead
compound
compound
vitro
activ
target
potenti
new
therapi
exploit
new
knowledg
develop
better
treatment
next
challeng
still
technic
challeng
overcom
proteom
must
deal
complex
mixtur
tissu
sampl
bodi
fluid
divers
sampl
complic
fact
protein
variou
isoform
variant
averag
singl
gene
produc
three
protein
protein
undergo
posttransl
modif
phosphoryl
glycosyl
increas
function
divers
furthermor
variou
gene
product
modif
differenti
tissu
express
function
protein
express
low
level
organ
cell
lowabund
protein
transcript
factor
cellsignal
protein
often
swamp
analysi
highabund
protein
eg
cytoskelet
protein
albumin
immunoglobulin
protein
fraction
enrich
techniqu
immunodeplet
may
concentr
lowabund
protein
analysi
combin
increas
sensit
instrument
start
overcom
problem
proteom
pattern
profil
offer
enorm
hope
earli
detect
diseas
obstacl
remain
becom
commonplac
clinic
practic
mass
spectrometri
identifi
thousand
protein
complex
algorithm
still
need
develop
valid
order
identifi
specif
versu
nonspecif
chang
effect
sampl
type
qualiti
proteom
pattern
normal
variat
need
investig
issu
cost
data
manag
need
resolv
differ
sampl
may
specif
storag
requir
preserv
protein
integr
consider
includ
effect
treatment
proteom
profil
major
challeng
integr
biochem
genet
proteom
data
better
understand
organ
diseas
state
system
biolog
emerg
crossdisciplinari
scienc
aim
integr
studi
organ
term
fundament
structur
rather
individu
cellular
molecular
makeup
system
anyth
gene
regul
cell
tissu
organ
organ
biochem
interact
given
time
place
cell
system
biolog
requir
simultan
investig
interact
compon
proteom
contribut
multidisciplinari
approach
studi
diseas
highlevel
bioinformat
comput
skill
requir
deal
interpret
complex
biolog
system
proteom
analysi
human
diseas
move
ahead
rapidli
appli
find
improv
understand
role
individu
protein
entir
cellular
pathway
initi
develop
diseas
intern
human
proteom
organis
hupo
form
vision
consolid
nation
region
proteom
organis
worldwid
network
encourag
spread
proteom
technolog
dissemin
knowledg
human
proteom
proteom
model
organ
effort
hupo
organis
databas
develop
proteom
normal
diseas
tissu
initi
help
acceler
investig
diseas
excit
challeng
integr
data
genom
analysi
differenti
function
structur
studi
protein
cross
refer
biolog
process
occur
diseas
develop
databas
expedit
highthroughput
costeffect
analysi
clinic
sampl
earli
detect
prognost
diagnost
therapeut
test
strategi
avail
doctor
ultim
patient
